TG Therapeutics Inc.
TGTX | NASDAQ
$57.55
+$0.39 (+0.68%)
Sep 22, 2026, 10:50 AM ET · Market open
Fiscal Year Period Ending | FY 2025 Dec 30, 2025 | FY 2024 Dec 30, 2024 | FY 2023 Dec 30, 2023 | FY 2022 Dec 30, 2022 | FY 2021 Dec 30, 2021 | FY 2020 Dec 30, 2020 |
|---|---|---|---|---|---|---|
Cash & Equivalents | 79.15M | 179.89M | 92.93M | 102.3M | 298.89M | 553.44M |
Short-Term Investments | 62.82M | 131.11M | 124.58M | 59.37M | 15.88M | 51.99M |
Long-Term Investments | 59.14M | 808K | 1.29M | 12.4M | 35.53M | n/a |
Other Long-Term Assets | 19.08M | 3.37M | 1.42M | 1.27M | 1.26M | 1.26M |
Receivables | 305.63M | 129.19M | 51.09M | n/a | 1.39M | n/a |
Inventory | 125.59M | 110.46M | 39.82M | n/a | n/a | n/a |
Other Current Assets | 57.58M | 15.72M | 5.34M | 2.36M | 2.88M | 1.08M |
Total Current Assets | 630.76M | 566.36M | 317.94M | 168.27M | 330.97M | 611.74M |
Property-Plant & Equipment | 6.28M | 7.15M | 8.15M | 10.82M | 11.07M | 11.84M |
Goodwill & Intangibles | n/a | n/a | 799K | 799K | 799K | 799K |
Total Long-Term Assets | 432.49M | 11.33M | 11.64M | 25.3M | 48.66M | 13.9M |
Total Assets | 1.06B | 577.69M | 329.59M | 193.57M | 379.63M | 625.64M |
Account Payables | 107.51M | n/a | n/a | n/a | n/a | n/a |
Deferred Revenue | 21.23M | 11.41M | 152K | n/a | n/a | n/a |
Short-Term Debt | 1.04M | n/a | n/a | n/a | 975K | 22.18M |
Other Current Liabilities | 23.97M | 78.11M | 52.12M | 51.62M | 62.97M | 63.71M |
Total Current Liabilities | 153.76M | 90.68M | 53.72M | 53.2M | 65.38M | 87.55M |
Long-Term Debt | 252.67M | 244.43M | 100.12M | 71.14M | 66.79M | 7.72M |
Other Long-Term Liabilities | -7.02M | n/a | n/a | n/a | n/a | n/a |
Total Long-Term Liabilities | 261.47M | 264.65M | 115.37M | 81.78M | 77.09M | 18.74M |
Total Liabilities | 415.23M | 355.33M | 169.09M | 134.99M | 142.48M | 106.29M |
Total Debt | 260.73M | 253.72M | 110.8M | 83.06M | 79.05M | 41.98M |
Book Value | 648.02M | 222.36M | 160.5M | 58.59M | 237.15M | 519.35M |
Book Value Per Share | 4.01 | 1.39 | 1.08 | 0.43 | 1.79 | 4.50 |
Common Stock | 159K | 156K | 151K | 146K | 143K | 141K |
Retained Earnings | -1.08B | -1.53B | -1.55B | -1.53B | -1.33B | -980.6M |
Comprehensive Income | n/a | n/a | n/a | n/a | n/a | n/a |
Shareholders Equity | 648.02M | 222.36M | 160.5M | 58.59M | 237.15M | 519.35M |
Total Investments | 121.96M | 131.91M | 125.86M | 71.78M | 51.41M | 51.99M |
Add to Watchlist
Select watchlists to add or remove TGTX